Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
Mast cell neoplasms are one of the most frequently diagnosed malignancies in dogs. The clinical picture, course, and prognosis vary substantially among patients, depending on the anatomic site, grade and stage of the disease. The most frequently involved organ is the skin, followed by hematopoietic...
Main Authors: | Michael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, Mauro Dacasto, Emir Hadzijusufovic, Olivier Hermine, Irina Sadovnik, Susanne Gamperl, Mathias Schneeweiss-Gleixner, Karoline V. Gleixner, Thomas Böhm, Barbara Peter, Gregor Eisenwort, Richard Moriggl, Zhixiong Li, Mohamad Jawhar, Karl Sotlar, Erika Jensen-Jarolim, Veronika Sexl, Hans-Peter Horny, Stephen J. Galli, Michel Arock, David M. Vail, Matti Kiupel, Peter Valent |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2021.755258/full |
Similar Items
-
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast Cells
by: Mathias Schneeweiss-Gleixner, et al.
Published: (2022-06-01) -
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H
by: Peter Valent, et al.
Published: (2014-01-01) -
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML
by: Mathias Schneeweiss-Gleixner, et al.
Published: (2019-12-01) -
Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues
by: Peter Valent, et al.
Published: (2020-11-01) -
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph<sup>+</sup> Chronic Myeloid Leukemia
by: Irina Sadovnik, et al.
Published: (2022-12-01)